The following Multiple Choice Questions are not endorsed by an Exam Board.
0 of 5 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 5 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Multiple Choice Question 1 of 5
Which of the following is NOT an indication for a urodynamic study in a patient with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)?CorrectIncorrect
Multiple Choice Question 2 of 5
Which of the following is NOT an indication for prostatectomy/transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)?CorrectIncorrect
Multiple Choice Question 3 of 5
The most common complication of transurethral resection of the prostate (TURP) is …CorrectIncorrect
Multiple Choice Question 4 of 5
Which of the following is NOT true about prostate-specific antigen (PSA)?CorrectIncorrect
Multiple Choice Question 5 of 5
Which one is NOT a risk factor for metastases in prostate cancer?CorrectIncorrect
Medical Therapy of Prostatic Symptoms (MTOPS) trial. This is a most important trial on medical management of prostate cancer.
Prostate testing for cancer and treatment (ProtecT) trial. This is a landmark trial that discusses the outcome of active surveillance versus curative treatment.
Prostate Evaluation for Clinically Important Disease: Sampling Using Image Guidance or Not? (PRECISION) trial. This trial discussed the role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer. It redefined the need for prostate biopsy and helps in avoiding unnecessary biopsy.
This link provides American Urology Association guidelines for benign enlargement of the prostate. Each aspect is discussed in a precise manner.
European Association of Urology (EAU) guidelines on prostate cancer. This is the current recommendation from the EAU to manage cancer of the prostate. It discusses each aspect of cancer.